ABIONYX (EPA:ABNX) | WebDisclosure

PRESS RELEASE

published on 05/06/2025 at 21:33, 1 year 3 months ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025

Euronext Paris Shares Total Voting Rights ABIONYX Pharma April 30 2025
BRIEF

published on 03/21/2025 at 07:35, 1 year 5 months ago

CIC Market Solutions recommande l'achat de l'action ABIONYX Pharma

Achat Biopharma Traitements Innovants ABIONYX Pharma CIC Market Solutions
BRIEF

published on 03/21/2025 at 07:35, 1 year 5 months ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 year 5 months ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma bénéficie de l'initiation à l'achat par CIC Market Solutions, un service du Crédit Mutuel Alliance Fédérale, avec une recommandation à l'achat

Crédit Mutuel ABIONYX Pharma CIC Market Solutions Biopharmacie Recommandation Achat
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 year 5 months ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
BRIEF

published on 02/28/2025 at 07:35, 1 year 6 months ago

ABIONYX renforce son engagement contre la Déficience LCAT

Autorisation De Mise Sur Le Marché Maladie Rare Déficience LCAT Biomédicament Maladie De Norum
BRIEF

published on 02/28/2025 at 07:35, 1 year 6 months ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
PRESS RELEASE

published on 02/28/2025 at 07:30, 1 year 6 months ago

Informations privilégiées / Autres communiqués
ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA

ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE

published on 02/28/2025 at 07:30, 1 year 6 months ago

Inside Information / Other news releases
ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation

ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF

published on 02/27/2025 at 19:25, 1 year 6 months ago

ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024

2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry

Published on 08/28/2026 at 14:00, 7 hours 23 minutes ago

Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 8 hours 23 minutes ago

Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 13 hours 18 minutes ago

Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 13 hours 18 minutes ago

Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 13 hours 23 minutes ago

Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate

View all ACCESSWIRE

Published on 08/28/2026 at 20:49, 33 minutes ago

Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 41 minutes ago

Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 2 hours 13 minutes ago

Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 3 hours 22 minutes ago

CPI Europe announces unaudited results for the first half of 2026
Published on 08/28/2026 at 18:00, 3 hours 23 minutes ago

Highlight Event and Entertainment AG publishes results for the first half of 2026

View all EQS

Published on 08/28/2026 at 18:27, 2 hours 56 minutes ago

Droits de vote au 31-07-2026
Published on 08/28/2026 at 18:25, 2 hours 58 minutes ago

Droits de vote au 30-06-2026
Published on 08/28/2026 at 17:45, 3 hours 38 minutes ago

STEF : Droits de vote au 31 07 2026
Published on 08/28/2026 at 06:55, 14 hours 28 minutes ago

Recticel Accelerates Profitable Growth
Published on 08/28/2026 at 06:55, 14 hours 28 minutes ago

Recticel versnelt winstgevende groei

View all LES ECHOS COMFI WIRE

News